Skip to main content
Premium Trial:

Request an Annual Quote

Sue MacLeman, William Keane

Premium
Benitec has appointed CEO Sue MacLeman to its board of directors as managing director.
 
MacLeman joined Benitec late last year. Before that, she was CEO of Australian biotech firm EqiTx.
 
She holds a BS in pharmacology from the University of Queensland.
 

 
Intellect Neurosciences has appointed William Keane to its board of directors.
 
Keane, who served as CFO and corporate secretary at antisense firm Genta until 2005, is currently a consultant, Intellect said.
 
He holds an MBA from Rutgers University School of Management and a BA in microbiology from Rutgers College.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.